Select a company

Go

Company Stage

  • Private (seed)
  • Private (post-seed)
  • Quoted

Sector

  • Energy and Renewables
  • IT & Communications
  • Chemicals & Materials
  • Biotech
  • Healthcare

University

  • University of Bath
  • University of Bristol
  • University of Cardiff
  • University of Glasgow
  • University of Leeds
  • King's College London
  • Queen Mary, University of London
  • University of Manchester
  • University of Nottingham
  • University of Oxford
  • University of Sheffield
  • University of Southampton
  • University of Surrey
  • Swansea University
  • University of York
  • Other

Stakeholder

  • IP Group
  • IP Venture Fund
  • Top 10 Holdings
    by value
Medical Equipment & Supplies

University: Bath

Company Stage: Private (post-seed)

Website: http://www.glythera.com

Glythera Ltd

Glythera Ltd, a young spin-out biotechnology company from the University of Bath, was set up to create a new generation of biological therapeutics through advanced glycosylation technologies. The company has core expertise in protein/peptide functionalisation and glycosylation technologies, imparting improved pharmacokinetic properties to biological therapeutics.

Glythera successfully raised its first round of investment in 2008, with research operations being conducted in dedicated laboratories situated on the campus of the University of Bath.

As at 31 Dec 2012

IP Group holding

 

32.2%

Holding represents undiluted beneficial equity interest excluding debt

Related news

02 Apr 2014
18 Feb 2014

There is currently no news available.

More portfolio news